Previous month:
August 2010
Next month:
October 2010

Report: Wisconsin's bioscience sector is small but growing

By Kathleen Gallagher of the Journal Sentinel

Sept. 29, 2010 8:00 a.m.

While the rest of the state's economy was shrinking by more than 3%, Wisconsin's bioscience sector grew by nearly 3%.

It's a small sector that employs just 1.1% of all the workers in the state, but it also provides much higher-than-average earnings.

Those findings for the six years that ended in December 2009 will be released Wednesday at a networking event in Madison organized by BioForward, a trade group for Wisconsin's biotech industry.

Combined with data from the 2009 Battelle Report on Biosciences Education, which ranks Wisconsin among the eight best states for science and math education at the grade school and high school levels, the findings suggest an industry with substantial advantages that the state needs to act on, said Bryan Renk, BioForward's executive director.

"If you combine the job growth, the demographics on average salary, and the data on education, this is where we're going to combat the brain drain issue," Renk said.

Full story.


Funding will extend the functionality and application of IB Neuro™

Elm Grove, WI –Imaging Biometrics LLC (IB), a biotechnology company specializing in the development of medical imaging software, has announced that it has received $800,000 in a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the continued development and distribution of novel and proven perfusion and diffusion analysis software for the evaluation of brain tumors and stroke. Funding during this two year program will be used to integrate key enhancements into IB Neuro™, the company’s flagship product.

Download Imaging Biometrics Phase II SBIR Final

Magical BEANs: New Nano-sized Particles Could Provide Mega-sized Data Storage

The ability of phase-change materials to readily and swiftly transition between different phases has made them valuable as a low-power source of non-volatile or “flash” memory and data storage. Now an entire new class of phase-change materials has been discovered by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the University of California (UC) Berkeley that could be applied to phase change random access memory (PCM) technologies and possibly optical data storage as well.  The new phase-change materials – nanocrystal alloys of a metal and semiconductor – are called “BEANs,” for binary eutectic-alloy nanostructures.

Full story.

Elm Grove firm inks licensing agreement with university

By Kathleen Gallagher of the Journal Sentinel

Sept. 8, 2010

An Elm Grove medical imaging software firm said Wednesday morning it has signed an exclusive licensing agreement with the University of Pennsylvania.

The agreement gives Imaging Biometrics LLC the right to develop and commercialize technology that could provide a more automated way to accurately evaluate a tumor's response to different treatments, the company said.

Full story.

State could lose millions in stem cell research funding

Congress could decide fate

By Jason Stein of the Journal Sentinel

Sept. 7, 2010

Wisconsin researchers and biotechnology companies stand to lose millions of dollars a year in federal funding for promising stem cell research because of a federal judge's ruling, Gov. Jim Doyle and university officials said Tuesday.

The State of Wisconsin will seek to file a friend of the court brief for an appeal to overturn that ruling, which temporarily blocked guidelines set down by President Barack Obama's administration expanding human embryonic stem cell research, Doyle said.

Also on Tuesday, U.S. District Judge Royce Lamberth in Washington ruled that the Obama administration can't continue to fund embryonic stem cell research while appealing a ban on government support for any activity using cells taken from human embryos.

Lamberth rejected the government's motion to reconsider his ruling last month enforcing the ban pending an appeal to the U.S. Court of Appeals in Washington. The Justice Department argued that Lamberth's injunction itself is causing irreparable harm to researchers, taxpayers and scientific progress.

Full story.